The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 24, 2018
Filed:
Mar. 27, 2015
Applicant:
Kancor Ingredients Ltd, Mumbai, Maharashtra, IN;
Inventors:
Alain Victor Khaiat, Singapore, SG;
Shaju Asokan Vaikkathukattil, Kerala, IN;
Ramesh Chandran Kalapurakkal, Kerala, IN;
Prakash Kumar Unnikrishnan, Kerala, IN;
Assignee:
KANCOR INGREDIENTS LTD, Mumbai, Maharashtra, IN;
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 8/49 (2006.01); A61K 8/27 (2006.01); A61K 8/29 (2006.01); A61K 8/35 (2006.01); A61K 8/37 (2006.01); A61K 8/44 (2006.01); A61Q 17/04 (2006.01); A61K 8/31 (2006.01); A61K 8/34 (2006.01); A61K 8/36 (2006.01); A61K 8/41 (2006.01); A61K 8/42 (2006.01); A61K 8/60 (2006.01); A61K 8/64 (2006.01); A61K 8/81 (2006.01); A61K 8/86 (2006.01); A61K 8/891 (2006.01); A61K 8/97 (2017.01);
U.S. Cl.
CPC ...
A61K 8/4973 (2013.01); A61K 8/27 (2013.01); A61K 8/29 (2013.01); A61K 8/31 (2013.01); A61K 8/34 (2013.01); A61K 8/342 (2013.01); A61K 8/345 (2013.01); A61K 8/347 (2013.01); A61K 8/35 (2013.01); A61K 8/361 (2013.01); A61K 8/37 (2013.01); A61K 8/41 (2013.01); A61K 8/42 (2013.01); A61K 8/445 (2013.01); A61K 8/496 (2013.01); A61K 8/4966 (2013.01); A61K 8/60 (2013.01); A61K 8/602 (2013.01); A61K 8/64 (2013.01); A61K 8/8194 (2013.01); A61K 8/86 (2013.01); A61K 8/891 (2013.01); A61K 8/97 (2013.01); A61Q 17/04 (2013.01); A61K 2800/52 (2013.01); A61K 2800/5922 (2013.01);
Abstract
The sunscreen composition includes dibenzoylmethane derivative in 1 to 5% by weight of the composition, octyl-methoxycinnamate in 1 to 10% by weight of the composition and dermatologically acceptable excipients in 79 to 97% by weight of the composition containing 60-75% aqueous phase stabilised with 1-(4-methoxy-5-benzofuranyl)-3-phenyl 1, 3 propanedione (pongamol) in 0.9 to 6% by weight of the composition.